demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 severe or critically
COVID 19 hospitalizedCOVID-19 severe or critically
canakinumab Sheng ... CAN-COVID

0 studies excluded by filtering options 0